Anabolic Laboratories, Inc. Announces Name Change to Nexgen Pharma(TM), Inc.

IRVINE, Calif., Jan 09, 2007 /PRNewswire via COMTEX/ -- Anabolic Laboratories, Inc., an 80-year old company manufacturing both pharmaceutical products and dietary supplements, has changed its name to Nexgen Pharma(TM), Inc. No other changes within the company are taking place except for the name change and logo, which are effective as of January 1, 2007. The name "Nexgen Pharma(TM), Inc." was created to reflect the current business strategies driving the company's growth.

"Although our company name and logo has changed, our customers and business partners can be assured that we will continue to deliver the same dependable service they've counted on us for, throughout the years," stated President and CEO, Steve Brown.

About Nexgen Pharma(TM), Inc.
Nexgen Pharma(TM), Inc. (formerly Anabolic Laboratories, Inc.) has an 80-plus year history of manufacturing pharmaceutical and nutritional products with a rigorous commitment to quality and customer satisfaction. These commitments have helped position the company as one of the leading contract manufacturers in the industry. Nexgen Pharma(TM), Inc. manufactures products from start to finish in its own facilities and can offer pharmaceuticals, medical foods, OTC drugs and dietary supplements. Whether the customer's needs are in the area of product development, ANDA submission or scaling up products ready for commercial production, Nexgen Pharma(TM), Inc. can meet those needs in an expedient, cost effective fashion.

Nexgen Pharma(TM), Inc. has four facilities located in Irvine, California, Tempe and Phoenix, Arizona and Columbia, Missouri, which total over 150,000 square feet of manufacturing, laboratory and warehouse / distribution space. For more information visit

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.